Mithra
Barbara Vrancken is an experienced sales professional in the pharmaceutical industry, currently serving as Sales Manager national for Ceres Pharma since August 2018. Previously, Barbara held the position of District Manager at Mithra Pharmaceuticals from September 2013 and at Promomed s.a. between 2010 and 2013, where involvement included the Project Teva-Theramex. Barbara's career began as a Medical Representative at Norgine from 2000 to 2005, followed by similar roles at Heel Belgium (2005-2009) and Pharmadeal (1998-2000). Barbara holds a degree in Marketing and Management from Katholieke Hogeschool Limburg and CVO, completing studies between 1994 and 2000.
This person is not in any offices
Mithra
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com